脑脉泰胶囊联合磷酸川芎嗪片治疗短暂性脑缺血发作疗效观察

Observation of Clinical Therapeutic Effect of Transient Ischemic Attack Treated with Naomaitai Jiaonang and Ligustrazine Phosphate Tablets

目的观察脑脉泰胶囊联合磷酸川芎嗪片治疗短暂性脑缺血发作(TIA)的临床疗效。方法将462例TIA患者随机分成3组:脑脉泰胶囊组患者给予脑脉泰胶囊1.0g,口服,3次/d;磷酸川芎嗪片组患者给予磷酸川芎嗪片100mg,口服,3次/d;联合用药组患者给予脑脉泰胶囊联合磷酸川芎嗪片,用法及用量同上。治疗后比较3组患者的疗效。结果脑脉泰胶囊组、磷酸川芎嗪片组和联合用药组有效率分别为64.54%(91/141)、34.15%(56/164)、90.45%(142/157)。联合用药组的疗效最佳。结论脑脉泰胶囊联合磷酸川芎嗪片治疗TIA效果显著优于单独用药。

Objective To observe the clinical therapeutic effect of transient ischemic attack（TIA） treated with Naomaitai Jiaonang combine Ligustrazine Phosphate Tablets.Methods 462 cases who suffered from TIA were divided into three groups：Naomaitai Jiaonang group：Naomaitai Jiaonang 1.0g,oral,tid.Ligustrazine Phosphate Tablets group：Ligustrazine Phosphate Tablets 100 mg,oral,tid.Naomaitai Jiaonang combine Ligustrazine Phosphate group：Naomaitai Jiaonang1.0g and Ligustrazine Phosphate Tablets 100mg,oral,tid.Compare the curative effect of three groups after treatment.Results The effective power of three groups were 64.54%（91/141,Naomaitai Jiaonang group）、34.15%（54/164,Naomaitai Jiaonang group） and 90.45%（142/157,Naomaitai Jiaonang combined Naomaitai Jiaonang group）respectively.The curative effect of Naomaitai Jiaonang combined Naomaitai Jiaonang group was the best.Conclusion Treatment of TIA,Naomaitai Jiaonang combined Ligustrazine Phosphate Tablets were outweighed than single medication.